{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:35:48Z","timestamp":1784183748728,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIMH through a Specialized Center of Research","award":["5P50 MH68036"],"award-info":[{"award-number":["5P50 MH68036"]}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"crossref","award":["U01NS038455"],"award-info":[{"award-number":["U01NS038455"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources \u2014 (NCRR","doi-asserted-by":"crossref","award":["M01-RR00039"],"award-info":[{"award-number":["M01-RR00039"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.yebeh.2014.02.011","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T01:03:38Z","timestamp":1395018218000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Carbamazepine clearance and seizure stability during pregnancy"],"prefix":"10.1016","volume":"33","author":[{"given":"Emily L.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary N.","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Jeffrey","family":"Newport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanee L.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page B.","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.02.011_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0b013e3181a6b325","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0015","author":"International League Against Epilepsy"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0020","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2014.02.011_bb0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2014.02.011_bb0035","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1212\/WNL.61.6_suppl_2.S35","article-title":"Antiepileptic drug pharmacokinetics during pregnancy and lactation","volume":"61","author":"Pennell","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2014.02.011_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2008-1041385","article-title":"Pharmacokinetics of antiepileptic drugs during pregnancy","volume":"8","author":"Leppik","year":"1988","journal-title":"Semin Neurol"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0010","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1212\/01.wnl.0000289511.20864.2a","article-title":"Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency","volume":"70","author":"Pennell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00007691-198507030-00005","article-title":"Carbamazepine protein binding and disposition in pregnancy","volume":"7","author":"Yerby","year":"1985","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00003088-197904010-00005","article-title":"Antiepileptic drugs: metabolism in pregnancy","volume":"4","author":"Dam","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-198510030-00007","article-title":"Plasma concentrations of carbamazepine and carbamazepine 10,11-epoxide during pregnancy and after delivery","volume":"10","author":"Battino","year":"1985","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.yebeh.2014.02.011_bb0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1528-1157.1994.tb02921.x","article-title":"Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin","volume":"35","author":"Tomson","year":"1994","journal-title":"Epilepsia"},{"issue":"4 Suppl. 5","key":"10.1016\/j.yebeh.2014.02.011_bb0065","first-page":"12","article-title":"Antiepileptic drug disposition during pregnancy","volume":"42","author":"Yerby","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.0b013e3181a6b312","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2013.06.026","article-title":"Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy","volume":"29","author":"Reisinger","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.yebeh.2014.02.011_bb0080","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/epi.12302","article-title":"Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry","volume":"54","author":"Battino","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.02.011_bb0085","series-title":"Maternal, fetal, and neonatal physiology: a clinical perspective","author":"Blackburn","year":"2013"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T22:21:57Z","timestamp":1538778117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501400047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":17,"alternative-id":["S152550501400047X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.02.011","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbamazepine clearance and seizure stability during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}